PTEN and hepatocellular carcinoma: In terms of mechanism, inhibition of LINC01296 inhibits the growth of HCC in vivo, inhibits the proliferation, migration, and invasion of HCC cells in vitro, and plays a role in the occurrence and development of HCC by regulating the miR-26a/PTEN signaling pathway [50].